Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Ansell.
RELATED STOCKHEAD STORIES
News
Lunch Wrap: Trump’s metals tariff drags ASX; WiseTech addresses new allegations
Health & Biotech
Health Check: Ansell gloves up for Trump tariff threat
Health & Biotech
Scott Power: ASX health stocks drop as Trump’s proposed tariffs rattle global markets
Health & Biotech
Biocurious: From drug prices to efficiency drives, ASX biotechs await the ‘Trumpcare’ health fallout
Health & Biotech
Scott Power: Which company dropped 30pc on its latest quarterly result?
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise but are ‘lacking any momentum’
Health & Biotech
ScoPo’s Powerplays: ASX health stocks hit resistance in first week of FY25
Health & Biotech
ASX Health Stocks: Immuron gives vicious cycle kick in the guts
News
Traders’ Diary: Everything you need to get ready for the week ahead
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, Mach7 eyes cashflow positive in FY24
News
Closing Bell: ASX gains as lithium, iron ore miners dazzle; copper and gold stocks extend rally
News
ASX Small Caps Lunch Wrap: Which country’s gone full-on Footloose this week?
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Large Caps: ANZ and Suncorp get merger approval, Star crashes 22pc after revealing second probe
Health & Biotech
ScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpoint
Experts
MoneyTalks: The Greatest Wealth is Health, says Morningstar’s Shane Ponraj and Virgil
Health & Biotech
